Page 5 - Nasdaq Mack News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) and Centessa Pharmaceuticals (NASDAQ:CNTA – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability. Institutional & Insider Ownership 55.9% of Merrimack Pharmaceuticals shares […]

StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report released on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Merrimack Pharmaceuticals stock opened at $5.20 on Friday. Merrimack Pharmaceuticals has a fifty-two week low of $3.66 and a fifty-two week high of $7.41. The stock […]

StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $5.58 on Wednesday. The stock’s 50-day moving average is $6.24 and its two-hundred day moving average is $5.15. The stock has […]

StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK stock opened at $6.24 on Monday. Merrimack Pharmaceuticals has a 12 month low of $3.66 and a 12 month high of $7.97. The […]

StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report released on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock. Shares of NASDAQ MACK opened at $6.39 on Friday. The stock has a market capitalization of $85.69 million, a P/E ratio of -35.50 and a […]